| ZFIN ID: ZDB-EXP-210304-1 |
Experiment Conditions Description: light damage: posterior cardinal vein, chemical treatment by environment: rivaroxaban
| light damage: posterior cardinal vein |
|---|
| Name: | light damage |
|---|---|
| Synonyms: | |
| Definition: | Physical alteration which uses light to damage the anatomical structure, cell, or organ. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000245] |
| Name: | posterior cardinal vein |
|---|---|
| Synonyms: | axial vein, caudal cardinal veins, PCV, postcardinal vein |
| Definition: | Continuation of the caudal vein cranial to the anal pore. The cardinal vein splits into a pair of vessels in the cranial trunk, just caudal to the radix of the aorta. The posterior cardinals each empty into the common cardinal vein. |
| Ontology: | Anatomy Ontology [ZFA:0000477] |
| chemical treatment by environment: rivaroxaban |
|---|
| Name: | chemical treatment by environment |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000238] |
| Name: | rivaroxaban |
|---|---|
| Synonyms: | 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, BAY 59-7939, BAY59-7939, rivaroxaban, Xarelto |
| Definition: | A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-chlorothiophene-2-carboxylic acid with the amino group of 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one. An anticoagulant used for prophylaxis of venous thromboembolism in patients with knee or hip replacement surgery. |
| Ontology: | ChEBI [CHEBI:68579] ( EBI ) |
| Publication: | Grzegorski et al., 2020 |
|---|